<DOC>
	<DOCNO>NCT01976767</DOCNO>
	<brief_summary>Cross-sectional study characterize cohort subject asthma healthy control term clinical feature , physiological measurement non-invasive measurement biomarkers develop phenotype handprints adult severe asthma</brief_summary>
	<brief_title>Longitudinal Assessment Adults With Severe Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>General 1 . Able give write informed consent prior participation study , include ability comply requirement restriction list consent form . Informed consent must obtain prior undertake study procedure . 2 . Male female subject age 18 year old screening . 3 . Able complete study measurement . 4 . Able read , comprehend , write sufficient level complete study related material . 5 . Subjects allow enrol study take part study . However , Permission Scientific Board must obtain enrol allow continue participation subject enrol another study . General 1 . As result medical interview , physical examination screen investigation physician responsible considers subject unfit study either risk subject due study influence may study result . 2 . The subject history recreational drug use allergy , , opinion responsible physician , contraindicate participation . 3 . Subject female pregnant lactate 6 week post partum 6 week cessation breast feeding . If woman subsequently find pregnant time assessment data assessment include analysis . 4 . The subject participate within 3 month first dose study use new molecular entity , first dose study investigate drug participate within three month study invasive procedure . Any UBIOPRED assessment defer 3 month first dose invasive procedure . Permission Scientific Board must obtain enroll allow continue participation subject enrol another study . 5 . Those , opinion investigator , risk noncompliance study procedure . 6 . The subject recent history incapacitate psychiatric disorder 7 . History current evidence upper low respiratory infection symptom ( include common cold ) within 2 week baseline assessment ( assessment defer ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Sputum</keyword>
	<keyword>Clinical cohort</keyword>
	<keyword>Smokers</keyword>
	<keyword>Asthma</keyword>
	<keyword>Biopsies</keyword>
	<keyword>Severe asthma</keyword>
	<keyword>Collaborative research</keyword>
	<keyword>Phenotyping</keyword>
	<keyword>Lipidomics</keyword>
	<keyword>Transcriptomics</keyword>
	<keyword>Proteomics</keyword>
	<keyword>Paediatric cohort</keyword>
	<keyword>Systems Biology</keyword>
</DOC>